AFYX Therapeutics bags $13 mln
San Diego-based AFYX Therapeutics, a clinical stage biopharmaceutical company, has secured $13 million in convertible loan financing. Sofinnova Ventures was the lead investor.
24 June 2019•1 min read
San Diego-based AFYX Therapeutics, a clinical stage biopharmaceutical company, has secured $13 million in convertible loan financing. Sofinnova Ventures was the lead investor.
